Fort Point Capital Partners’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,700	Closed	-$25.2K	–	320
2024 Q1	$25.2K	Hold	1,700	–	–	﹤0.01%	316
2023 Q4	$24.7K	Hold	1,700	–	–	﹤0.01%	291
2023 Q3	$18.4K	Hold	1,700	–	–	﹤0.01%	275
2023 Q2	$21.9K	Hold	1,700	–	–	﹤0.01%	279
2023 Q1	$22.4K	Hold	1,700	–	–	﹤0.01%	258
2022 Q4	$25.5K	Hold	1,700	–	–	﹤0.01%	251
2022 Q3	$20K	Hold	1,700	–	–	﹤0.01%	256
2022 Q2	$19K	Hold	1,700	–	–	﹤0.01%	262
2022 Q1	$51K	Hold	1,700	–	–	0.01%	274
2021 Q4	$45K	Hold	1,700	–	–	0.01%	276
2021 Q3	$62K	Hold	1,700	–	–	0.01%	243
2021 Q2	$74K	Hold	1,700	–	–	0.01%	156
2021 Q1	$58K	Hold	1,700	–	–	0.01%	143
2020 Q4	$60K	Hold	1,700	–	–	0.01%	138
2020 Q3	$41K	Hold	1,700	–	–	0.01%	125
2020 Q2	$31K	Hold	1,700	–	–	0.01%	122
2020 Q1	$27K	Hold	1,700	–	–	0.01%	100
2019 Q4	$36K	Hold	1,700	–	–	0.01%	114
2019 Q3	$32K	Hold	1,700	–	–	0.01%	112
2019 Q2	$44K	Hold	1,700	–	–	0.02%	101
2019 Q1	$44K	Hold	1,700	–	–	0.02%	105
2018 Q4	$39K	Hold	1,700	–	–	0.02%	131
2018 Q3	$55K	Hold	1,700	–	–	0.02%	144
2018 Q2	$48K	Hold	1,700	–	–	0.02%	120
2018 Q1	$60K	Hold	1,700	–	–	0.02%	155
2017 Q4	$66K	Hold	1,700	–	–	0.03%	127
2017 Q3	$43K	Hold	1,700	–	–	0.02%	132
2017 Q2	$46K	Buy	+1,700	New	+$46K	0.03%	96